Mechanism of Action: Cholinergic Muscarinic Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cholinergic Muscarinic Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-002 | Jun 19, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-004 | Sep 17, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-003 | Jun 19, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rafa Labs Ltd | ATROPINE (AUTOINJECTOR) | atropine | SOLUTION;INTRAMUSCULAR | 212319-001 | Jul 9, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb Inc | ATROPINE SULFATE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 213581-001 | Mar 15, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
